{"id":"W2601767411","doi":"10.1200/jco.2013.31.15_suppl.8542","title":"Phase (Ph) I/II study of elotuzumab (Elo) plus lenalidomide/dexamethasone (Len/dex) in relapsed/refractory multiple myeloma (RR MM): Updated Ph II results and Ph I/II long-term safety.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Lenalidomide; Neutropenia; Gastroenterology; Regimen; Internal medicine; Dexamethasone; Adverse effect; Cohort; Toxicity","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001155184,0.0008617903,0.000787299,0.0003198952,0.0002383037,0.0006453718,0.0005670073,0.0005249932,0.002841202],"category_scores_gemma":[0.0005091177,0.0003359524,0.0007708553,0.0003083401,0.0003305165,0.0004577647,0.0003606012,0.001626942,0.0005894262],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005844875,"about_ca_system_score_gemma":0.0009674007,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006380739,"about_ca_topic_score_gemma":0.001711292,"domain_scores_codex":[0.9997441,0.0001144269,0.00001557646,0.00004511229,0.00003523593,0.00004549531],"domain_scores_gemma":[0.9995857,0.00004641885,0.00011539,0.00002987837,0.00003466078,0.0001880505],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5923305,0.05789471,0.04552873,0.001177727,0.002197602,0.0006195625,0.0004577198,0.002916852,0.09069779,0.0003379936,0.008590231,0.1972506],"study_design_scores_gemma":[0.4992617,0.4021966,0.07310271,0.0001030652,0.001421011,0.001109469,0.0001172965,0.001178452,0.01110286,0.0002922894,0.01007715,0.00003737457],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9881006,0.002085795,0.0007915753,0.0003795207,0.00004995677,0.003357948,0.002613498,0.00008086043,0.00254021],"genre_scores_gemma":[0.9849881,0.001809399,0.002168293,0.001235192,0.000123532,0.002002785,0.005248955,0.00003033367,0.002393393],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002841202,"threshold_uncertainty_score":0.009504795,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1078135320933281,"score_gpt":0.4502282269040533,"score_spread":0.3424146948107253,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}